VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 113 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $618,000 | -39.2% | 234,981 | -4.5% | 0.06% | -44.7% |
| Q2 2021 | $1,016,000 | +226.7% | 246,004 | +273.0% | 0.11% | +119.2% |
| Q1 2021 | $311,000 | +135.6% | 65,946 | +357.2% | 0.05% | +57.6% |
| Q1 2020 | $132,000 | -80.6% | 14,425 | -70.5% | 0.03% | -58.2% |
| Q4 2019 | $681,000 | +59.9% | 48,824 | +97.4% | 0.08% | +36.2% |
| Q3 2019 | $426,000 | +16.1% | 24,730 | +28.9% | 0.06% | +56.8% |
| Q1 2019 | $367,000 | +14.3% | 19,178 | -43.9% | 0.04% | 0.0% |
| Q4 2018 | $321,000 | -46.0% | 34,200 | +12.5% | 0.04% | +27.6% |
| Q2 2018 | $594,000 | – | 30,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |